Changing Interactions Between Physician Trainees and the Pharmaceutical Industry: A National Survey
- 27 February 2013
- journal article
- research article
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 28 (8) , 1064-1071
Abstract
Increasingly, medical school policies limit pharmaceutical representatives’ access to students and gifts from drugmakers, but little is known about how these policies affect student attitudes toward industry.Keywords
This publication has 30 references indexed in Scilit:
- Medical Students' Exposure to and Attitudes about the Pharmaceutical Industry: A Systematic ReviewPLOS Medicine, 2011
- Closing the Door on Pharma? A National Survey of Family Medicine Residencies Regarding Industry InteractionsAcademic Medicine, 2011
- Strategies and Practices in Off-Label Marketing of Pharmaceuticals: A Retrospective Analysis of Whistleblower ComplaintsPLOS Medicine, 2011
- Funding for Medical Education: Maintaining a Healthy Separation From IndustryCirculation, 2010
- Impact of pharmaceutical representative visits on GPs' drug preferencesFamily Practice, 2009
- Pharmaceutical Industry Financial Support for Medical Education: Benefit, or Undue Influence?Journal of Law, Medicine & Ethics, 2009
- The Hidden Curriculum: Medical Students’ Changing Opinions toward the Pharmaceutical IndustryAcademic Medicine, 2007
- Physicians and Drug Representatives: Exploring the Dynamics of the RelationshipJournal of General Internal Medicine, 2007
- Attitudes of Preclinical and Clinical Medical Students Toward Interactions with the Pharmaceutical IndustryAcademic Medicine, 2007
- Changes in drug prescribing patterns related to commercial company funding of continuing medical educationJournal of Continuing Education in the Health Professions, 1988